World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
37315
World Ranking
7396
National Ranking
421

Overview

Thomas Klingebiel is a researcher affiliated with Goethe University Frankfurt in Germany. Their work primarily falls within the field of Medicine, with particular emphasis on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Hematology, and Pediatrics, Perinatology and Child Health.

The scientist has contributed extensively to topics including:

  • Sarcoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Tumors and Oncological Cases
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation

Notable recent research papers authored or co-authored by Thomas Klingebiel include:

  • "Sarcoma classification by DNA methylation profiling" (2021), published in Nature Communications
  • "Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia" (2021), published in JAMA
  • "Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study" (2020), published in Bone Marrow Transplantation
  • "Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR" (2020), published in Annals of Oncology
  • "Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)" (2023), published in Journal of Clinical Immunology

Their frequent collaborators include:

  • Peter Bader
  • Ewa Kościelniak
  • Monika Sparber-Sauer
  • Gustaf Ljungman
  • Bernd Gruhn

Thomas Klingebiel's work appears regularly in journals such as:

  • Pediatric Blood & Cancer
  • Monatsschrift Kinderheilkunde
  • Bone Marrow Transplantation
  • Cancers
  • Klinische Pädiatrie

Best Publications

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

    Beate Kempf-Bielack;Stefan S. Bielack;Heribert Jürgens;Detlev Branscheid

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Alfred Reiter;Martin Schrappe;Markus Tiemann;Wolf-Dieter Ludwig

  • Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

    Einsele H;Ehninger G;Hebart H;Wittkowski Km

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

    Frank Berthold;Joachim Boos;Stefan Burdach;Rudolf Erttmann

  • Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

    Peter Bader;Hermann Kreyenberg;Günter H.R. Henze;Cornelia Eckert

  • The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

    Wilhelm Woessmann;Kathrin Seidemann;Georg Mann;Martin Zimmermann

  • Megadose transplantation of purified peripheral blood CD34 + progenitor cells from HLA-mismatched parental donors in children

    R Handgretinger;T Klingebiel;P Lang;P Lang;M Schumm;M Schumm

  • Breast carcinoma during pregnancy. International recommendations from an expert meeting.

    Sibylle Loibl;Gunter von Minckwitz;Karin Gwyn;Paul Ellis

  • Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

    Gesche Tallen;Richard Ratei;Georg Mann;Gertjan Kaspers

  • Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87

    Hagen Graf Einsiedel;Arend von Stackelberg;Reinhard Hartmann;Rüdiger Fengler

  • Sarcoma classification by DNA methylation profiling

    Christian Koelsche;Christian Koelsche;Daniel Schrimpf;Daniel Schrimpf;Damian Stichel;Martin Sill

  • A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

    R. Handgretinger;K. Anderson;P. Lang;R. Dopfer

  • Results of Treatment for Soft Tissue Sarcoma in Childhood and Adolescence: A Final Report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

    Ewa Koscielniak;Dieter Harms;Günter Henze;Herbert Jürgens

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

Frequent Co-Authors

Peter Bader
Peter Bader Goethe University Frankfurt
Peter Lang
Peter Lang University of Bern
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Ulrike Koehl
Ulrike Koehl Leipzig University
Halvard Bonig
Halvard Bonig Goethe University Frankfurt
Thomas Lehrnbecher
Thomas Lehrnbecher Goethe University Frankfurt
Martin Schrappe
Martin Schrappe Kiel University
Dietrich Niethammer
Dietrich Niethammer University of Tübingen
Arndt Borkhardt
Arndt Borkhardt Heinrich Heine University Düsseldorf
Simone Fulda
Simone Fulda Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare careers or need flexible learning options, several online degree programs and career pathways complement medical studies in the USA. Many students begin by becoming a registered nurse with an associate degree in nursing through online adn programs that offer accessible admissions and convenient coursework.

For registered nurses seeking career advancement, there are cheap rn to bsn online programs designed to be affordable and to fit within a working nurse’s busy schedule. These bridge programs can lead to higher earning potential and new opportunities in specialized areas of care.

Individuals from non-nursing backgrounds may consider pursuing nursing directly through direct entry online msn programs. These accelerated pathways are ideal for motivated career changers who want to quickly transition into advanced nursing roles.

If your interest is in healthcare administration or support roles, you might ask, can you get financial aid for medical billing and coding? Accredited online programs in medical billing and coding often have financial assistance, making training for this in-demand field more accessible.

Best Scientists Citing Thomas Klingebiel

Trending Scientists